abc-logo
  • Latest Articles
  • Diseases
    • Autoimmune Diseases
      • Arthritis
      • Crohn's Disease
      • Juvenile Arthritis
      • Lupus
      • Rheumatoid Arthritis
      • Type 1 Diabetes
      • Type 2 Diabetes
    • Cancer
      • Myeloma
      • Leukemia
      • Lymphoma
      • Breast Cancer
      • Cervical Cancer
      • Brain Cancer
      • Colon Cancer
      • Kidney Cancer
      • Stomach Cancer
      • Lung Cancer
      • Skin Cancer
    • Heart Diseases
      • Heart Transplant
      • Heart Disease
      • High Cholesterol
      • Obesity
    • Infectious Diseases
      • Coronavirus
      • HIV/AIDS
      • Hepatitis C
      • HPV
    • Mental Health
      • Depression
      • Schizophrenia
      • Bipolar Disorder
    • Neurological Diseases
      • ALS
      • Alzheimer's
      • Epilepsy
      • Migraine
      • Multiple Sclerosis
      • Parkinson's
    • Treatment Approaches
      • Genomics
      • Vaccines
      • Immunologic
      • Treatments
  • About Us
    • Our Commitment
      • Development Pipeline
      • Innovation Fragility
      • Innovation Offsets
      • Accessibility & Affordability
      • R&D Commitment
    • Faces of Innovation
      • Champions / Advocates
      • Patient Profiles
      • Researcher Profiles
    • Member Companies
      • Who We Are
    • Campaigns
      • Breakthrough
      • Together
      • Do Not Go Gentle
      • New World
      • Cells
      • New Era of Medicine
    • Collaboration & Events
      • Events
  • SEARCH
  •  STAY AHEAD
  • Take Action
We Cannot Take Progress for Granted
  1. Home
  2. About Us
  3. Our Commitment
  4. Innovation Fragility
  5. Policy Solutions to Push Progress Forward

Policy Solutions to Push Progress Forward

Innovation Fragility
Advocacy / Policy
Our Commitment
Accessibility & Affordability
Innovation Offsets
Policy Issues

Innovation Requires Policy Solutions

We are in a new era of medical discovery with the potential and power to revolutionize treatment for costly and debilitating diseases. But we must not take this progress for granted. To ensure medical innovation continues for patients, we need public policies that take into account the investment and time needed to develop life-saving treatments and cures.

 

To enhance competition and improve affordability for patients, our country must:

  1. Make Medicines More Affordable by Rewarding Better Outcomes for Patients

  2. Ensure Patients Get the Best Deal on Medicines

  3. Make New Breakthroughs Accessible and Promote Competition

 

Learn more about these goals below.

 

GET THE LATEST IN INNOVATION NEWS

Subscribe to receive the latest in medical innovation, treatment insights, and inspirational stories.

SUBSCRIBE NOW

 

 

1. Make Medicines More Affordable by Rewarding Better Outcomes for Patients

 

Breakthrough medicines are revolutionizing how we fight disease, but too often patients have to fight with insurers to access these treatments. We can improve patient access and affordability by moving toward a system that prioritizes results for patients.

 

Different patients respond differently to different medicines. How we pay for medicines should reflect these differences. That’s why America’s biopharmaceutical companies are working with insurers to develop innovative and flexible ways to pay for medicines that focus on results, lower out-of-pocket costs and enable patients to access the right treatments the first time.

 

In order for biopharmaceutical companies to pursue more and larger scale value-based arrangements, we need to modernize regulations developed for an earlier era. Recently the U.S. Food and Drug Administration (FDA) released guidance on communications with payers, which was a substantial and positive step forward in allowing biopharmaceutical companies to communicate in support of value-based arrangements. However, additional barriers to these arrangements remain. We need to reform regulations that discourage companies from offering discounts that are tied to outcomes, rather than volume. And we need to clarify existing Medicaid best price requirements that inhibit companies from entering into a range of new payment arrangements.

 

The right public policies can encourage innovative private-sector solutions to provide patients with affordable access to new medicines.

2. Ensure Patients Get the Best Deal on Medicines

 

While biopharmaceutical companies set the list price for a brand medicine, more than one-third is rebated back to payers and the supply chain. Insurers negotiate large rebates, but often do not share these discounts with patients.

 

Private payers reportedly receive rebates between 30 and 70 percent for medicines that treat a number of chronic conditions including diabetes, asthma, hepatitis C and high cholesterol. Yet, these negotiated discounts are most often not shared with patients who pay a deductible or a coinsurance – a percentage of costs a patient is responsible for paying out of pocket – for their medicine at the pharmacy. We need to ensure patients receive access to these rebates at the pharmacy counter. Providing access to discounted prices could dramatically lower patients’ out-of-pocket costs. See how we're changing the conversation.

Learn how we can make medicines more affordable at LetsTalkAboutCost.org

Read More
PhRMA COVID Treatment Tracker Thumbnail

We Are Committed to Act, Treat and Defend

America’s biopharmaceutical companies are coming together to achieve one common goal: ending COVID-19. Our shared heritage of discovery and research allows us to respond to the coronavirus swiftly, with active trials for both treatments and vaccines already underway.

Learn More

 

3. Make New Breakthroughs Accessible and Promote Competition

 

We need to make it easier for patients to access breakthrough medicines. It simply takes too long to get new medicines approved – between 10 to 12 years. The U.S. Food and Drug Administration has been focused on efforts to enhance the drug development and review process and laws recently enacted are a step forward to helping to make the process better.

 

To enhance our ability to bring new medicines to patients, we need keep pace with 21st century science by incorporating new and innovative approaches to the drug development process. Innovative clinical trial design, patient perspectives and real-world evidence all hold potential speed the development and review of innovative new medicines and enhance the competitive marketplace.

 

At the same time, we must avoid policies that deter risk-taking or siphon funding away from the research and development of new medicines that can improve patients’ lives. Learn more about our plan to build a sustainable, science-based health care system that harnesses today’s hopes to discover tomorrow’s cures here.

 


RELATED TOPICS

Innovation Fragility
Advocacy / Policy
Our Commitment
Accessibility & Affordability
Innovation Offsets
Policy Issues

Share:

  • #GoBoldly

POPULAR ARTICLES

From An Acute Fatal Disease to A Chronic, Manageable Condition Image

HIV/AIDS: From An Acute Fatal Disease to A Chronic, Manageable Condition

<p>The evolution of HIV/AIDS treatment is nothing short of remarkable. In the 1980s, HIV/AIDS was an acute fatal disease. Today it is a chronic, manageable condition thanks to the commitment of biopharmaceutical researchers, health care workers and advocates.</p>

READ MORE

Combatting Sickle Cell Disease with Cell & Gene Therapy

<p><span><span><span><a><span lang="EN"><span>America's biopharmaceutical companies are researching and developing new treatments to alleviate the tremendous burden of this devastating and painful disease and to improve the quality of life for sickle cell patients.</span></span></a></span></span></span></p>

READ MORE
Why Has Research into Alzheimer's Disease Been So Hard thumbnail

Why Has Research into Alzheimer's Disease Been So Hard?

<p>Why, when we have seen such progress in our ability to treat other diseases, such as cancer, diabetes and HIV, has progress in Alzheimer's research been so difficult to achieve?</p>

READ MORE

5 Recent Developments Advancing Vaccines

As communities continue to grapple with the impact of COVID-19, vaccines have once again come to the forefront as a critical health care tool.

READ MORE
Gloved hands using pipette and test tubes.

The Innovation Ecosystem Fuels Breakthroughs

Biopharmaceutical research companies are uniquely positioned to take the necessary risks to further advance research into safe and effective treatments for patients.

READ MORE
Blood Cancer Awareness Month: The Promise of Immunotherapy thumbnail

Blood Cancer Awareness Month: The Promise of Immunotherapy

<p>September is Blood Cancer Awareness Month, which aims to raise awareness for patients with one of several types of blood cancer, including leukemia, lymphoma and myeloma.</p>

READ MORE
Protecting Alzheimer's Research Thumbnail

Protecting Alzheimer's Research

15 million people will live with Alzheimer's by 2060. We're working to change that.

READ MORE

Explore the innovative research and technological breakthroughs of America's biopharmaceutical industry, and get to know the people behind the fight to prevent, treat and cure disease.

abc-logo
Privacy Policy Patient Resources Terms of Service PhRMA.org

©2018 Pharmaceutical Research and Manufacturers of America, 950 F Street NW, Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.

  • DISEASES
  • Cancer
  • Heart Diseases
  • Infectious Diseases
  • Autoimmune Diseases
  • Mental Health
  • Neurological Diseases
  • Treatment Approaches

  • Take Action

  • About Us
  • Collaboration & Events
  • Our Commitment
  • Member Companies
  • Campaigns
  • Faces of Innovation
Privacy Policy Patient Resources Terms of Service PhRMA.org

©2018 Pharmaceutical Research and Manufacturers of America, 950 F Street NW, Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how we and third parties use pixel tags, and how that use affects you, click here.